Treatment of glioma with virotherapy and TNF-\(\alpha\) inhibitors: analysis as a dynamical system
From MaRDI portal
Publication:1678324
DOI10.3934/dcdsb.2018029zbMath1376.92027OpenAlexW2765284076MaRDI QIDQ1678324
Heinz Schättler, Elzbieta Ratajczyk, Urszula Łedzewicz-Kowalewska, Maciej Leszczynski
Publication date: 14 November 2017
Published in: Discrete and Continuous Dynamical Systems. Series B (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.3934/dcdsb.2018029
Medical applications (general) (92C50) Control/observation systems governed by ordinary differential equations (93C15)
Related Items (2)
Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors ⋮ Spatial model for oncolytic virotherapy with lytic cycle delay
Cites Work
- The role of TNF-\(\alpha\) inhibitor in glioma virotherapy: a mathematical model
- Nonlinear oscillations, dynamical systems, and bifurcations of vector fields
- Modeling of cancer virotherapy with recombinant measles viruses
- Optimization of virotherapy for cancer
- A mathematical model for cell cycle-specific cancer virotherapy
- Unnamed Item
This page was built for publication: Treatment of glioma with virotherapy and TNF-\(\alpha\) inhibitors: analysis as a dynamical system